The therapeutic potential of ADAM15
Neali Lucas1, Abdo J Najy, Mark L Day
1Department of Urology, University of Michigan, Ann Arbor, MI 48109-5944, USA.
Abstract:
ADAM15 is a widely expressed multi-domain protease that has been implicated in the pathogenesis of many human diseases. Given the diversity of the ADAM15 functional domains, this protease is thought to affect several important cellular processes, including cell adhesion, degradation of extracellular matrix components, and ectodomain shedding of membrane-bound growth factors that are intrinsic to cancer and various inflammatory conditions. The multiple levels by which the activity of ADAM15 can be regulated include signal transduction, modulation of catalytic function, spatial regulation, and post-translational modifications. Taken together, this multi-functional disintegrin protease not only offers a variety of potential targets for therapeutic intervention, but also represents an attractive target for pharmaceutical consideration due to its involvement in key cellular processes and various disease states. Modalities aimed at inhibiting protease activation, metalloproteinase activity, or integrin binding capability could prove beneficial for the treatment of cancer and inflammatory diseases.
Insights
ADAM15, a protease involved in cell adhesion and matrix degradation, plays a role in cancer and inflammation. Inhibiting its activity may offer therapeutic benefits for these diseases.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- ADAM15 is a widely expressed protease implicated in human disease pathogenesis.
- Its diverse functional domains influence cell adhesion, extracellular matrix degradation, and growth factor shedding.
- These processes are critical in cancer and inflammatory conditions.
Purpose of the Study:
- To explore the multifaceted roles of ADAM15 in cellular processes.
- To highlight ADAM15 as a potential therapeutic target for diseases like cancer and inflammation.
Main Methods:
- The abstract does not specify methods, but implies analysis of ADAM15's structure-function relationships and disease involvement.
- Discussion of regulatory mechanisms including signal transduction, catalytic function, spatial regulation, and post-translational modifications.
Main Results:
- ADAM15's activity is regulated through multiple pathways.
- Its involvement in key cellular processes makes it a significant factor in disease states.
Conclusions:
- ADAM15 is a multi-functional protease with therapeutic potential.
- Inhibiting protease activation, metalloproteinase activity, or integrin binding of ADAM15 could treat cancer and inflammatory diseases.
Related Concept Videos
01:30Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
01:18Adrenergic Agonists: Therapeutic Classification
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase